NASDAQ: NVAXNovavax Inc Stock Ownership
Insider buying vs selling
Have Novavax Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gary C. Evans | Director | 2021-06-01 | 625 | $146.50 | $91.56kSell |
| John A. Iii Herrmann | EVP Chief Legal Officer | 2021-05-28 | 417 | $46.00 | $19.18kBuy |
| John A. Iii Herrmann | EVP Chief Legal Officer | 2021-05-28 | 2,062 | $5.95 | $12.27kBuy |
| John A. Iii Herrmann | EVP Chief Legal Officer | 2021-05-28 | 517 | $149.81 | $77.45kSell |
| John A. Iii Herrmann | EVP Chief Legal Officer | 2021-05-28 | 240 | $151.08 | $36.26kSell |
| John A. Iii Herrmann | EVP Chief Legal Officer | 2021-05-28 | 416 | $27.60 | $11.48kBuy |
| John A. Iii Herrmann | EVP Chief Legal Officer | 2021-05-28 | 70 | $153.49 | $10.74kSell |
| John A. Iii Herrmann | EVP Chief Legal Officer | 2021-05-28 | 864 | $147.85 | $127.74kSell |
| John A. Iii Herrmann | EVP Chief Legal Officer | 2021-05-28 | 1,109 | $148.88 | $165.10kSell |
| John A. Iii Herrmann | EVP Chief Legal Officer | 2021-05-28 | 95 | $152.11 | $14.45kSell |
NVAX insiders have sold more NVAX shares than they have bought in the last year
Ownership
NVAX Shareholders
What type of owners hold Novavax Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Pharmaceuticals Ltd Cadila | 12.82% | 9,500,000 | $1.99B | Insider |
| James B. 1. Tananbaum | 8.46% | 6,268,455 | $1.31B | Insider |
| Vanguard Group Inc | 7.95% | 5,893,304 | $1.24B | Institution |
| Blackrock Inc | 7.39% | 5,473,023 | $1.15B | Institution |
| Fmr LLC | 6.47% | 4,790,910 | $1.00B | Institution |
| Strategic Investments Llc Sj | 5.40% | 4,001,500 | $839.03M | Insider |
| Thomas P. Monath | 4.36% | 3,232,366 | $677.76M | Insider |
| Ra Capital Management LP | 4.05% | 3,002,087 | $629.48M | Institution |
| Rajiv I. Modi | 3.37% | 2,500,000 | $524.20M | Insider |
| State Street Corp | 1.95% | 1,441,953 | $302.35M | Institution |
Novavax Stock Ownership FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.